Samuel Rahbar

2.2k total citations
32 papers, 1.8k citations indexed

About

Samuel Rahbar is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Samuel Rahbar has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Clinical Biochemistry, 13 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Genetics. Recurrent topics in Samuel Rahbar's work include Advanced Glycation End Products research (14 papers), Natural Antidiabetic Agents Studies (10 papers) and Hemoglobinopathies and Related Disorders (9 papers). Samuel Rahbar is often cited by papers focused on Advanced Glycation End Products research (14 papers), Natural Antidiabetic Agents Studies (10 papers) and Hemoglobinopathies and Related Disorders (9 papers). Samuel Rahbar collaborates with scholars based in United States, Iran and Italy. Samuel Rahbar's co-authors include James L. Figarola, Helen M. Ranney, Olga O. Blumenfeld, Noe Gonzales, Rama Natarajan, Jerry L. Nadler, Stephen Scott, Stephen H. Scott, Sanjay Awasthi and Sharad S. Singhal and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer Research.

In The Last Decade

Samuel Rahbar

31 papers receiving 1.7k citations

Peers

Countries citing papers authored by Samuel Rahbar

Since Specialization

Citations

This map shows the geographic impact of Samuel Rahbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Rahbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Rahbar more than expected).

Fields of papers citing papers by Samuel Rahbar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Rahbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Rahbar. The network helps show where Samuel Rahbar may publish in the future.

Co-authorship network of co-authors of Samuel Rahbar

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Rahbar. A scholar is included among the top collaborators of Samuel Rahbar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Rahbar. Samuel Rahbar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LR-90 prevents methylglyoxal-induced oxidative stress and apoptosis in human endothelial cells 2014 ·APOPTOSIS ·James L. Figarola, Jyotsana Singhal, Samuel Rahbar, Sanjay Awasthi, Sharad S. Singhal	57
2	COH-SR4 Reduces Body Weight, Improves Glycemic Control and Prevents Hepatic Steatosis in High Fat Diet-Induced Obese Mice 2013 ·PLoS ONE ·James L. Figarola, Preeti Singhal, Samuel Rahbar, Bogdan G. Gugiu, Sanjay Awasthi, Sharad S. Singhal	27
3	Novel compound 1,3-bis (3,5-dichlorophenyl) urea inhibits lung cancer progression 2013 ·Biochemical Pharmacology ·Sharad S. Singhal, James L. Figarola, Jyotsana Singhal, Lokesh Dalasanur Nagaprashantha, David Berz, Samuel Rahbar, Sanjay Awasthi	13
4	Small-molecule COH-SR4 inhibits adipocyte differentiation via AMPK activation 2013 ·International Journal of Molecular Medicine ·James L. Figarola, Samuel Rahbar	38
5	1,3-Bis(3,5-dichlorophenyl) urea compound ‘COH-SR4’ inhibits proliferation and activates apoptosis in melanoma 2012 ·Biochemical Pharmacology ·Sharad S. Singhal, James L. Figarola, Jyotsana Singhal, (unknown), Lokesh Dalasanur Nagaprashantha, Christopher Lincoln, Bogdan G. Gugiu, David Horne, Richard Jove, Sanjay Awasthi, Samuel Rahbar	20
6	Novel dichlorophenyl urea compounds inhibit proliferation of human leukemia HL-60 cells by inducing cell cycle arrest, differentiation and apoptosis 2011 ·Investigational New Drugs ·James L. Figarola, Yehua Weng, Christopher Lincoln, David Horne, Samuel Rahbar	25
7	Novel inhibitors of glycation and AGE formation 2007 ·Cell Biochemistry and Biophysics ·Samuel Rahbar	62
8	Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors 2005 ·Diabetes/Metabolism Research and Reviews ·James L. Figarola, Steven D. Scott, Sofia Loera, Bixin Xi, Timothy W. Synold, Lawrence M. Weiss, Samuel Rahbar	18
9	The Discovery of Glycated Hemoglobin: A Major Event in the Study of Nonenzymatic Chemistry in Biological Systems 2005 ·Annals of the New York Academy of Sciences ·Samuel Rahbar	89
10	Renoprotective and Lipid‐Lowering Effects of LR Compounds, Novel Advanced Glycation End Product Inhibitors, in Streptozotocin‐Induced Diabetic Rats 2005 ·Annals of the New York Academy of Sciences ·James L. Figarola, Steven D. Scott, Sofia Loera, Bixin Xi, Timothy W. Synold, Samuel Rahbar	16
11	Novel inhibitors of advanced glycation endproducts 2003 ·Archives of Biochemistry and Biophysics ·Samuel Rahbar, James L. Figarola	285
12	Novel Inhibitors of Advanced Glycation Endproducts (Part II) 2000 ·PubMed ·Samuel Rahbar, (unknown), Stephen Scott, Noe Gonzales, (unknown)	98
13	Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation 2000 ·Clinica Chimica Acta ·Samuel Rahbar, Rama Natarajan, (unknown), Stephen H. Scott, Noe Gonzales, Jerry L. Nadler	128
14	Novel Inhibitors of Advanced Glycation Endproducts 1999 ·Biochemical and Biophysical Research Communications ·Samuel Rahbar, (unknown), Stephen Scott, Noe Gonzales, (unknown)	44
15	A new rapid method to detect inhibition of Amadori product generated by δ-gluconolactone 1999 ·Clinica Chimica Acta ·Samuel Rahbar, Jerry L. Nadler	18
16	Mild sickle cell anemia associated with alpha globin mutant alpha montgomery 1989 ·The American Journal of Medicine ·Josef T. Prchal, (unknown), Samuel Rahbar, Ronald L. Nagel, Abdullah Kutlar, J. H. Galla, Kelly E. Hall	3
17	Fetal hemoglobin gene activation in a phase II study of 5,6-dihydro-5-azacytidine for bronchogenic carcinoma. 1987 ·PubMed ·Brian I. Carr, Samuel Rahbar, James H. Doroshow, Douglas W. Blayney, David M. Goldberg, Lucille Leong, (unknown)	17
18	A Silent Hemoglobin Variant Detected by Hplc: Hemoglobin City of Hope β69 (E13) Gly → Ser 1984 ·Hemoglobin ·Samuel Rahbar, Yayesh Asmerom, Karl G. Blume	20
19	Hemoglobin: Structure, function, evolution, and pathology 1983 ·The American Journal of Human Genetics ·Samuel Rahbar	10
20	An abnormal hemoglobin in red cells of diabetics 1968 ·Clinica Chimica Acta ·Samuel Rahbar	277

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact